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Background:The role of the amyloid precursor protein (APP) in neural stem/progenitor cell (NSPC) proliferation is poorly
understood.
Results: Immunodepletion of cystatin C from NSPC conditioned medium abrogated an effect of APP on NSPC proliferation.
Conclusion: Cystatin C mediates APP-induced NSPC proliferation.
Significance: The results increase understanding of mechanisms promoting NSPC survival and differentiation.
The amyloid precursor protein (APP) is well studied for its
role in Alzheimer disease. However, little is known about its
normal function. In this study, we examined the role of APP in
neural stem/progenitor cell (NSPC) proliferation. NSPCs
derived fromAPP-overexpressing Tg2576 transgenic mice pro-
liferated more rapidly than NSPCs from the corresponding
background strain (C57Bl/6xSJL) wild-type mice. In contrast,
NSPCs from APP knock-out (APP-KO) mice had reduced pro-
liferation rates when compared with NSPCs from the corre-
sponding background strain (C57Bl/6). A secreted factor, iden-
tified as cystatin C, was found to be responsible for this effect.
Levels of cystatin C were higher in the Tg2576 conditioned
medium and lower in the APP-KO conditioned medium. Fur-
thermore, immunodepletion of cystatin C from the conditioned
medium completely removed the ability of the conditioned
medium to increase NSPC proliferation. The results demon-
strate that APP expression stimulates NSPC proliferation and
that this effect is mediated via an increase in cystatin C
secretion.
Neural stem cells are self-renewing, multipotent cells that
can produce all of the major cellular phenotypes in the nervous
system (1, 2). Neural stem cells are important, not only because
they produce the entire complement of neuronal and glial cells
of the mature nervous system and continue to generate new
neurons throughout life, but also because theymay be useful for
the therapeutic replacement of cells in neurodegenerative dis-
eases. Themechanisms that promote neural stemor progenitor
cell (NSPC)4 proliferation are only partially understood. Both
epidermal growth factor (EGF) and basic fibroblast growth fac-
tor (bFGF) are well studied for their roles in stimulating NSPC
proliferation in vitro (2, 3). However, other autocrine growth
factors produced by the NSPCs themselves may also be neces-
sary for optimum growth.
The -amyloid precursor protein (APP) is a 110–130-kDa
integral type I transmembrane glycoprotein that has been
extensively studied for its role in Alzheimer disease (AD) (4).
Despite the very large number of published studies on APP, the
normal function of APP has remained a mystery. APP is
encoded by a single gene located on chromosome 21 (5). APP is
post-translationally glycosylated and phosphorylated and can
be cleaved by two major proteolytic pathways. In one pathway,
sequential cleavage of APP by - and -secretase generates a
large ectodomain fragment (sAPP), which is secreted into the
extracellular milieu, and a small C-terminal fragment (the APP
intracellular domain or AICD), which may have a role in regu-
lating gene expression. In the other pathway, cleavage ofAPPby
- and -secretase generates a different ectodomain fragment
(sAPP), as well as the AICD peptide. Cleavage of APP via this
second pathway also generates the -amyloid protein (A) of
AD (6).
Although the normal function of APP is poorly understood,
the pattern of expression of APP suggests that it may be impor-
tant for neuronal growth and differentiation, not only in the
developing brain but also in the mature or aging nervous sys-
tem. The expression of APP has been shown to increase as
the nervous system matures (7). APP expression increases as
NSPCs mature into neurons, and soluble APP has been
reported to promote neural differentiation (8, 9). APPmay also
play a role in later stages of neuronal development. For exam-
ple, soluble APP is reported to stimulate neurite outgrowth in a
variety of cell systems (10–14). Our studies have shown that
APP expression is increased in the olfactory neuroepithelium at
the developmental stage when neurogenesis and neurite out-
growth begin (15). Similarly, APP has been reported to regulate
a number of developmental functions including neuronal
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migration (16) and cell growth (17, 18). A role for APP in cell
growth is supported by the rapid up-regulation of APP that
occurs in response to axonal injury (19–21). Dystrophic neu-
rites found around amyloid plaques are highly immunoreactive
for APP (22–24), consistent with the possibility that APP may
play a role in neural repair.
Neurogenesis is reported to be increased in transgenic mice
that overexpress APP. For example, Jin et al. (25) reported a
2-fold increase in BrdU-labeled cells in PDGF-APPsw,Ind mice
at 3 months of age. More recently, López-Toledano and Shel-
anski (26) reported similar findings. The increase in neural pre-
cursor proliferation was attributed either to a compensatory
mechanism resulting fromdisease pathology in themice (25) or
to a direct effect of A (26).
To address the role of APP in NSPC proliferation and neu-
rogenesis, we have examined the growth and proliferation in
culture of NSPCs derived from APP transgenic mice (Tg2576)
and from APP knock-out (APP-KO) mice. We report that the
proliferation rate of NSPCs from APP-overexpressing cells is
increased and that the proliferation of NSPCs from APP-KO
cells is decreasedwhen comparedwith the corresponding back-
ground strain NSPCs. Furthermore, we report that this effect is
mediated by a secreted factor. Despite previous suggestions
that sAPP can influence the growth of neural stem cells (9, 27,
28), we did not find any evidence that the effect on NSPCs is
mediated by sAPP. Instead, we demonstrate that APP-in-
duced NSPC proliferation is mediated, at least in part, by
secreted cystatin C.
EXPERIMENTAL PROCEDURES
Materials—Synthetic human sequence A peptides (95%
pure) were obtained from the Keck Biotechnology Resource
Laboratory (New Haven, CT). Dulbecco’s modified Eagle’s
medium (DMEM), B27 supplement, and poly-L-lysine were
from Life Technologies Australia Pty. Ltd. (Mulgrave, Austra-
lia). Penicillin, streptomycin, human recombinant sAPP, and
human recombinant EGF were all obtained from Sigma-Al-
drich Pty. Ltd. (Castle Hill, Australia). Human recombinant
bFGF was from PeproTech (Rocky Hill, NJ). The anti-A
monoclonal antibody (mAb) 6E10 was from Covance Pty. Ltd.
(North Ryde, New South Wales, Australia). Mouse recombi-
nant cystatin C, anti-mouse cystatin C antibody, affinity-puri-
fied polyclonal goat immunoglobulin G, and normal goat
immunoglobulin Gwere fromR&DSystems Inc. (Minneapolis,
MN). Anti-III tubulin mAb was from Promega Australia
(Alexandria, Australia). Normal mouse immunoglobulin G,
anti-goat horseradish peroxidase-conjugated secondary anti-
body, and anti-mouse horseradish peroxidase-conjugated sec-
ondary antibodywere fromDakoAustralia Pty. Ltd. (Campbell-
field, Australia). Newborn pups (postnatal day 0) of APP-KO
mice (fromThe Jackson Laboratory, Bar Harbor,ME) and their
correspondingwild-type background strain controls (C57Bl/6),
as well as human APP-overexpressing mice (APPSW Tg2576,
from Taconic Farms Inc., Hudson, NY) and their correspond-
ing background strain controls (C57Bl/6SJL), were used for
this study. Mice were housed in the animal facility at the Uni-
versity of Tasmania. All experimentswere approved by theUni-
versity of Tasmania Animal Ethics Committee.
Neurosphere and Isolated NSPC Cultures—Primary neuro-
sphere cultures derived from cerebral cortices of newbornmice
(postnatal day 0) were prepared according to the procedure of
Millet et al. (29). Brain cortices were cleared of meninges and
hippocampus and then incubated in 1TrypLETM Express
with EDTA (Life Technologies Australia) for 10 min at 37 °C.
Tissue was disrupted mechanically with a 1000-l fine tip, and
then the tissue was passed through a 40-m cell strainer (BD
Biosciences, North Ryde, Australia) to remove undissociated
cells. The single neurospheres were prepared by growing cells
in suspension in T75 cell culture flasks at a density of 20,000
cells/ml in proliferation medium (DMEM supplemented with
2% B27, penicillin (100 units/ml), streptomycin (100 units/ml),
human bFGF (20 ng/ml), and human EGF (20 ng/ml). After 7
days in culture, neurospheres were dissociated mechanically
with 200-l fine tips, and cells were counted in a hemocy-
tometer and then either reseeded as suspension cultures or
replated as adherent cultures in 200 l per well of proliferation
medium on poly-L-lysine-coated 96-well plates at a density of
2000 cells/well. All cultures were incubated in a humidified
incubator at 37 °C with 5% CO2.
In Vitro Assays of Cell Number and Proliferation—Cell num-
ber was measured by alamarBlue assay (28). Dissociated cells
cultured adherently on poly-L-lysine-coated 96-well plates
were incubated for up to 6 days, and then 20 l of alamarBlue
reagent (Life Technologies Australia) was added into each well,
and the cells were incubated for a further 4 h. The fluorescence
intensity was determined using a FLUOstar Optimamicroplate
fluorescence plate reader at an excitationwavelength of 540 nm
and an emission wavelength of 590 nm. Cell number was
expressed as the relative fluorescence intensity.
Cell proliferation wasmeasured by EdU incorporation. After
4 days in proliferation medium, cells were incubated with EdU
for 8 h as described previously (30).
Analysis of Differentiation of NSPCs—Neurospheres were
mechanically dissociated, and then isolated cells were plated at
a density of 105 cells/well in 24-well plate. The cells were grown
in a differentiation medium (DMEM containing 1% fetal calf
serum (FCS), 2% B27 supplement, 100 units/ml penicillin, and
100 units/ml streptomycin) for 5 days at 37 °C in an atmosphere
containing 5% CO2. The cells were fixed in 4% paraformalde-
hyde in phosphate-buffered saline (PBS) (8 g/liter NaCl, 0.2
g/liter KCl, 1.44 g/liter Na2HPO4, and 0.24 g/liter KH2PO4, pH
7.2) for 15min, permeabilized with 0.03% (v/v) Triton X-100 in
PBS for 5min, and then blocked in 4% goat serum in PBS for 20
min. Fixed cells were stained withmouse anti-III tubulin anti-
body (1:1000 diluted in 2% goat serum in PBS) and then incu-
batedwith a goat anti-mouse IgG conjugated toAlexa Fluor 488
(1:1000 diluted in 2% goat serum in PBS) and counterstained
with 4,6-diamidino-2-phenylindole (DAPI) at 1:7000 dilution.
Effect of Conditioned Medium on NSPC Proliferation—Con-
ditionedmediumwas collected from neurosphere cultures that
had been grownover a period of 7 days. To examine the effect of
conditioned medium on NSPC proliferation, dissociated cells
from neurospheres were cultured adherently on poly-L-lysine-
coated 96-well plates in 100 l/well of proliferation medium.
Sixteen hours after plating, 100 l of conditioned medium or
normal proliferationmedium (control) was added, and the cells
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were incubated for 3 or 5 days, after which proliferation was
measured using the alamarBlue assay.
Immunoblotting—The level of sAPP and cystatin C in con-
ditioned medium was determined by Western blotting. The
volume per well of conditioned medium that was analyzed was
adjusted so that it represented the same number of viable cells,
as determined using the alamarBlue assay. Routinely,10–30
l was loaded into each gel lane for analysis. For the analysis of
intracellular cystatin C, cells were washed with PBS and then
lysed as described previously (31) prior to analysis by Western
blotting.
Proteins were separated on 8% (sAPP) or 12% (cystatin C)
sodium dodecyl sulfate-polyacrylamide (SDS-PAGE) gels
before being transferred electrophoretically onto polyvi-
nylidene difluoride (PVDF) membranes. Membranes were
blocked for 1 h with 5% skim milk powder in 50 mM Tris-buff-
ered saline (pH 8) containing 0.05% Tween 20 (TBS-Tween)
and incubated overnight at 4 °C with either anti-APP antibody
(22C11 at 1:1000 dilution or 6E10 at 1:1000 dilution) or anti-
cystatin C antibody (1:1000 dilution). Chemiluminescence
reactions were monitored using a CHEMI-SMART 5000, and
images were collected using Chemi-Capt 50001. For quantifi-
cation of immunoreactivity, images of blots were analyzed
using ImageJ version 1.46.
Immunoprecipitation—For depletion of sAPP or cystatin C
from conditioned medium, mAb 6E10, anti-mouse cystatin C
antibody, or goat immunoglobulin G (35 g) was incubated
with 500 l of protein G agarose gel (Roche Products Pty. Ltd.,
Dee Why, Australia) overnight at 4 °C in 5 ml of PBS. The gel
was then washed three times with 5 ml PBS, after which the gel
was incubated with 5.5 ml of conditioned medium for 3 h at
4 °C. Finally, the gel slurry containing conditionedmediumwas
centrifuged (10,000 g), and the resulting supernatant fraction
was assayed by Western blotting or used for cell proliferation
experiments.
Real-time PCR—RNA was extracted from the neurospheres
of n 6 independent mouse cohorts using an RNeasy mini kit
(Qiagen Pty. Ltd., Chadstone, Australia) as described by the
manufacturer. Each preparation of neurospheres contained
106 cells. Six independent RNA extracts were obtained from
each neurosphere preparation. cDNA was obtained from 400
ng of RNAwith an RT2 First Strand kit (Qiagen) as described by
the manufacturer. The cystatin C primers (Cst3) were from
Qiagen, and the glyceraldehyde-3-phosphate dehydrogenase
(GAPDH)primerswere fromGeneworks Pty. Ltd. (Hindmarsh,
Australia). GAPDHwas used as an internal control. All primers
were used at a concentration of 10M. All samples were diluted
1:10 and analyzed in triplicate. Standard curves for Cst3 and
GAPDH with concentrations 1, 0.5, 0.25, and 0.125 g were
used to quantify Cst3 mRNA using SYBRmaster mix (Qiagen).
The results were analyzed using a LightCycler 480 (RocheDiag-
nostics Australia Pty. Ltd., Castle Hill, Australia).
Statistical Analysis—Statistical analysis was performed with
GraphPad Prism software, version 5.04. Data were tested by
one-way ANOVA or Student’s t test. Post hoc comparisons
were analyzed using Tukey’s test. Differences were considered
statistically significant when p  0.05. Data values are pre-
sented as themeans S.E. All results were derived from at least
three independent experiments in which cells were derived
from at least three different mice of the same strain.
RESULTS
We first examined the level of APP in neurosphere cultures
to confirm that the level of APP expression was higher in the
Tg2576 cultures than in the background strain (C57Bl/6xSJL)
littermate control cultures. At 2, 4, and 6 days after plating,
conditionedmediumwas analyzed forAPPbyWestern blotting
with mAb 22C11,which recognizes both mouse and human
APP and the APP homologue amyloid protein-like protein-2,
and with mAb 6E10, which recognizes human sAPP. The
results confirmed that APP levels were much higher in the
medium of Tg2576 neurosphere cultures than in the back-
ground strain cultures (Fig. 1A). A major band of 100–110 kDa
was detected in the medium, corresponding to the molecular
mass of sAPP.
Next, to examine the role of APP in NSPC proliferation, we
compared the proliferation of cells derived from Tg2576 mice
with that of the background strain controls. Neurosphere cul-
tureswere dissociated into a single cell suspension onday 7, and
then cells were cultured adherently on poly-L-lysine-coated
96-well plates. The proliferation of the cellswasmeasuredusing
an alamarBlue assay. Fluorescence intensity in an alamarBlue
assay was taken as an index of the number of viable cells. Over-
all, the growth rate of the cells derived from the Tg2576 mice
was significantly greater (p 0.05, one-way ANOVAwith post
hoc Tukey’s test) than that of the cells derived from the back-
ground strain mice (Fig. 1B).
We also examined the growth of neurospheres to determine
whether the proliferation of NSPCs was increased in the
Tg2576 cultures. Neurospheres were cultured for a period of 7
days, after which they were examined under phase-contrast
microscopy (Fig. 1, C and D). Neurospheres derived from
Tg2576 mice were on average greater in size than the neuro-
spheres from the background strain mice, confirming that the
growth of NSPCs in Tg2576 cultures was greater than that of
the background strain cultures.
To confirm that the increased growth of the Tg2576 NSPC
was due to a higher proliferation rate, we measured prolifera-
tion using an EdU uptake assay (30). The percentage of EdU-
positive cells in the Tg2576 cultures was20% higher than the
cultures derived from background strain mice (Fig. 1E). These
results clearly supported the view that the increased growth
observed using the alamarBlue assay and in the neurosphere
cultures was due to an increase in the amount of NSPC
proliferation.
To determine whether the higher proliferation rate of the
Tg2576 cells was also associated with a higher potential for
neuronal differentiation, isolated NSPCs, grown adherently,
were transferred to a differentiation medium containing 1%
FCS but lacking EGF and bFGF. The cells were incubated over 5
days and then immunostained for the neuronal marker III-
tubulin (Fig. 2). The results showed that there was an increased
proportion of neurons in the Tg2576 cell population when
compared with the cells derived from the background strain
(C57Bl/6xSJL)mice (Fig. 2). Tg2576 cells also possessed longer,
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more extensive neurite networks than the background strain
cells.
To examine whether expression of endogenous mouse APP
influences NSPC proliferation and to rule out the possibility
that the increase in proliferation observed in Tg2576 cultures
was due to a factor unrelated to APP overexpression, we also
examined the proliferation rate of NSPCs from APP-KO mice.
We found that NSPC proliferation was decreased in APP-KO
cultures when compared with the corresponding background
strain (C57Bl/6) cultures (Fig. 3). The growth rate of the
APP-KO cells, as assessed by an alamarBlue assay, was60% of
that of the cells derived from background strain mice (Fig. 3A).
Furthermore, neurospheres from APP-KO mice were smaller
and less numerous than theC57Bl/6 neurospheres (Fig. 3,B and
C). In addition, the percentage of proliferating EdU-positive
cells was also significantly decreased. These experiments
clearly demonstrated that endogenousAPPwas also involved in
the regulation of NSPC proliferation.
We also examined the capacity of APP-KO NSPCs to dif-
ferentiate using the same procedure as described previously
for the Tg2576 cells. The APP-KO cells were compared with
the corresponding C57Bl/6 background strain cells. The
total number of III-tubulin-positive cells was lower in the
APP-KO cultures than in the background strain cultures
(Fig. 4).
FIGURE 1.Analysis of APP levels andproliferation ofNSPCsderived fromTg2576mice andbackground strain C57Bl/6xSJLmice.A, Western blot analysis of
the level of APP in the conditionedmediumof neurosphere cultures. Blots were stainedwithmAb 22C11, which recognizes both human andmouse APP, andmAb
6E10, which is specific for human-sequence APP. B, analysis of the proliferation of NSPCs. Neurospheres were dissociated, and the isolated cells were seeded on
poly-L-lysine-coated96-well plates at adensity of 2000 cells/well. After 2, 4, or 6days in culture, the relativenumberof cellswas estimatedusing thealamarBlueassay.
Fluorescence intensitywastakenasan indexofcellnumber.ValuesaremeansS.E. (n3wells).C,phase-contrastmicroscopyofneurospheresafter7days inculture.
Scalebar200m.D, quantitationof theareaofneurospheres fromtheexperimentshowninC. ValuesaremeansS.E. (n200neurospheres).E, EdUincorporation
assay of cell proliferation. NSPCswere cultured in proliferationmedium for 4 days prior to incubation for 8 hwith EdU (30). The graph shows themean values ( S.E.)
of the percentage of cells incorporating EdU (n 30 incubations). * significantly different from corresponding values for the background strain C57BL/6xSJL cells
(p 0.05, experiment in panel B, one-wayANOVAwith post hoc Tukey’s test; experiment in panel D, Student’s t test).
FIGURE 2. Neuronal differentiation of NSPCs derived from C57Bl/6xSJL
and Tg2576 mice. Neurospheres were dissociated, and the resulting cells
were cultured adherently on poly-L-lysine for 5 days in differentiation
medium. The cells were then stained for III-tubulin (green) and counter-
stained with DAPI (red) to visualize cell nuclei. Scale bar 50 m. The figure
also shows quantitation of the percentage of III tubulin-positive cells for
both groups. Values are means  S.E. Twenty fields were counted for each
group. Each field contained100 DAPI-positive cells. * significantly differ-
ent from C57Bl/6xSJL group (p 0.05, Student’s t test).
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Wenext examinedwhether the effect ofAPPonproliferation
was mediated by a factor that was secreted into the culture
medium. Conditioned medium was prepared over 7 days from
Tg2576 and the corresponding background strain (C57Bl/
6xSJL) neurosphere cultures. In parallel, dissociated C57Bl/
6xSJL NSPCs were plated and incubated for 16 h. Conditioned
medium from the neurosphere cultures or unconditioned pro-
liferation medium was then added to the dissociated cell cul-
tures. The amount of proliferation wasmeasured after 5 days of
incubation. There was a higher rate of proliferation in cultures
containing conditioned medium (whether from C57Bl/6xSJL
or Tg2576 cells) than in cultures containing unconditioned
medium (Fig. 5A). Importantly, the conditioned medium from
Tg2576 cell cultures stimulated cell proliferationmore than the
conditioned medium from the C57Bl/6xSJL cultures, support-
ing the view that the increased proliferation in the Tg2576 cul-
tures was due to the secretion of a factor into the conditioned
medium.
To test this hypothesis further, we examined the effect of
conditionedmedium fromAPP-KO cell cultures onNSPC pro-
liferation. This time, isolated NSPCs grown adherently were
incubated with unconditioned medium (control), conditioned
medium from APP-KO neurosphere cultures, or conditioned
medium from the corresponding background strain C57Bl/6
neurosphere cultures (Fig. 5B). In contrast to the results with
Tg2576 cultures, the APP-KO conditioned medium was sig-
nificantly less potent in stimulating proliferation than the
background strain conditioned medium. This result again
supported the view that there was a factor secreted into
the medium of APP-expressing cells that increased cell
proliferation.
As it has been reported that sAPP can stimulate neural stem
cell proliferation or differentiation (9, 27, 28), we examined the
effect of recombinant human sAPP on proliferation in our
cultures. However, despite repeated experiments aimed at
determining whether sAPP can stimulate NSPC proliferation,
wewere unable to demonstrate any effect of sAPP over a range
of different concentrations (50–2000 ng/ml) (Fig. 6A). Despite
suggestions that A amyloid may stimulate stem cell prolifera-
tion (26), we were also unable to find any effect of A1–40 or
A1–42 on proliferation (Fig. 6A).
To rule out the possibility that the lack of effect of recombi-
nant sAPPmight be due to the fact that the protein was not in
a native conformation, we also tested the effect of removing
FIGURE 3.Analysis of proliferation of NSPCs derived fromAPP knock-out and fromC57Bl/6 (corresponding background strain)mice. A, neurospheres
were dissociated, and the isolated cells were seeded on poly-L-lysine-coated 96-well plates at a density of 2000 cells/well. After 2, 4, or 6 days in culture, the
relative number of cells was estimated using the alamarBlue assay. Fluorescence intensity was measured as an index of cell number. Values are means S.E.
(n  3 wells). *  significantly different from corresponding values for the background strain C57Bl/6 cells (p  0.05, one-way ANOVA). B, phase-contrast
microscopyof neurospheres after 7 days in culture. Scale bar 200m.C, quantitation of the area of neurospheres from the experiment shown in B. Values are
means S.E. (n 200 neurospheres). D, EdU incorporation assay of cell proliferation. The experiment was performed as described in the legend for Fig. 1. In
panels C and D, the asterisk shows values that are significantly different from C57Bl/6 cultures (p 0.05, Student’s t test).
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endogenous sAPP from the conditioned medium (Fig. 6B).
More than 98% of the endogenously expressed sAPP in the
conditioned mediumwas removed by immunoabsorption with
mAb 6E10 when compared with immunoabsorption with an
immunoglobulin (Ig) control (Fig. 6B, inset). However, despite
removal of most of the sAPP, there was no decrease in the
ability of the conditioned medium to stimulate proliferation.
On the basis of these experiments, we concluded that neither
sAPP nor A (both of which are fragments of full-length APP
that can be released into the culture medium) was the secreted
factor thatmediated the effect of APP overexpression onNSPC
proliferation.
As several studies have suggested that cystatin C is an impor-
tant autocrine regulator of neural stem cell proliferation (32,
33), we examined the possibility that cystatin C was the medi-
ator of APP-induced NSPC proliferation. Analysis of the con-
ditionedmedium from both Tg2576 cultures and APP-KO cul-
tures by Western blotting showed that cystatin C levels
correlatedwith the effect on proliferation (Fig. 7). In addition to
a major 14-kDa cystatin C band, an additional 16-kDa immu-
noreactive band was also present in the conditioned medium.
This higher molecular mass band may represent a post-trans-
lationally modified form of cystatin C (32). Consistent with the
view that the effect on proliferation was due to cystatin C,
we found that cystatin C immunoreactivity was elevated in the
Tg2576 conditioned medium (Fig. 7A), and lower in the
APP-KO cell conditioned medium (Fig. 7B).
To determine whether the changes in secreted extracellular
cystatin C reflected changes in the intracellular pools, we also
examined the level of cell-associated cystatin C (Fig. 7, C and
D). Surprisingly, the level of cystatin C in the cell lysates was
lower in both Tg2576 cultures and APP-KO cultures when
compared with the corresponding background strain cells for
each group. We also analyzed the level of cystatin C mRNA by
real-time PCR (Fig. 7, E and F). These experiments showed that
although the level of cystatin CmRNA expression was lower in
the APP-KO cells, there was no significant difference in expres-
sion in the Tg2576 cells.
Similar to previous studies (32, 33), cystatin C increased
NSPC proliferation in a concentration-dependent manner
(50–100 ng/ml cystatin C) (Fig. 8A). As the level of cystatin C in
the conditioned medium of background strain cells was higher
than this concentration range (Fig. 8B, panel i), this indicated
that the concentration of cystatin C in the conditionedmedium
in both wild-type and background strain cells was sufficiently
high to influence NSPC proliferation. Therefore, we tested
whether the endogenous secreted factor in the conditioned
medium was identical to cystatin C. We immunoprecipitated
cystatin C from the conditioned medium of both C57Bl/6xSJL
and Tg2576 cultures (Fig. 8B, panel ii) and measured the effect
of the immunodepleted medium on cell proliferation. Immu-
nodepletion of cystatin C from the conditioned medium com-
pletely removed the APP-associated increase in NSPC prolifer-
ation (Fig. 8C). Proliferation was not significantly decreased
when background strain NSPC conditioned medium was
immunodepleted of cystatin C. However, after immunodeple-
tion of cystatin C from the Tg2576 conditioned medium, the
level of NSPC proliferation was significantly lower than the
corresponding incubation in which the conditioned medium
was preabsorbed with Ig.
Similar results were obtained in separate experiments using
conditioned medium from C57Bl/6 and APP-KO cultures. In
these experiments, the immunodepleted conditioned medium
was tested on cultures of APP-KO cells (Fig. 8D). Immu-
nodepletion of cystatin C (Fig. 8B, panel iii) resulted in a signif-
icant decrease in proliferation of NSPCs when compared with
the corresponding incubations in which the conditioned
mediumwas preabsorbedwith Ig. Taken together, these results
clearly indicated that cystatin C was a major contributor to the
ability of APP to increase NSPC proliferation.
DISCUSSION
The present study demonstrates that APP expression regu-
lates the proliferation of NSPCs and that this effect is mediated,
at least in part, by an APP-stimulated increase in cystatin C
secretion. The results increase our understanding of both the
normal function of APP and themechanisms involved in neural
stem cell proliferation and differentiation.
Our findings also provide an explanation for previous studies
demonstrating that neural stem cell proliferation is increased in
transgenic mice that overexpress APP (25, 26). Studies by Jin et
al. (25) reported that neural stem cell proliferation was
increased in PDGF-APPsw,Ind mice. López-Toledano and Shel-
anski (26) confirmed and extended this observation in their
studies. In both studies, no clear demonstration of the mecha-
nism of increased proliferation was provided, although it was
suggested that the stimulation of proliferation may have been
due to A accumulation or some aspect of the associated A
pathology (25, 26). Our studies clearly support the view that
NSPC proliferation is directly influenced by the expression of
FIGURE 4. Neuronal differentiation of NSPCs derived from C57Bl/6 and
APP-KO mice. Neurospheres were dissociated, and the resulting cells were
cultured adherently onpoly-L-lysine for 5 days in differentiationmedium. The
cells were then stained for III-tubulin (green) and counterstained with DAPI
(red) to visualize cell nuclei. Scale bar 50m. The figure also shows quanti-
tation of the percentage of III tubulin-positive cells for both groups. Values
are means S.E. For each group, 24–27 fields were counted. Each field con-
tained 100 DAPI-positive cells. *  significantly different from C57Bl/6
group (p 0.05, Student’s t test).
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APP. Althoughwe cannot rule out the possibility that a product
of APP metabolism may be responsible for this effect, we did
not find any direct evidence that this effect was influenced by
sAPP or A peptides.
Interestingly, although neural stem cell proliferation is
increased inAPP-overexpressingmice, there is no obvious phe-
notype resulting from this increase. For example, prior to the
onset of AD-type pathology, the brains of young APP trans-
genic mice appear relatively normal. Nevertheless, subtle
abnormalities may be present in thesemice. For example, over-
expression of APP in transgenic mice is reported to lead to
changes in synaptic density (34), and Rodgers et al. (35) report
that APP transgenic mice exhibit persistent locomotor hyper-
activity. Whether these abnormalities are due to an increase in
the number of specific neuronal populations is unclear. In the
case of APP knock-out mice, there are clear abnormalities,
most notably agenesis of the corpus callosum (36). However,
whether this phenotype is due to a neural stem cell proliferation
deficit is also unclear.
A surprising finding to emerge out of these studies was that
the effect of APP overexpression was not mediated through
sAPP. A large number of studies have suggested that sAPP
has trophic properties on neural stem cells (9, 27, 28, 37, 38). In
our studies, recombinant human sAPP had no effect on
proliferation, nor did immunoprecipitation of endogenous
secreted mouse sAPP inhibit proliferation. Instead, we found
that immunoprecipitation of cystatin C from the culture
medium decreased the APP-induced stimulation, clearly dem-
onstrating that some of the effect on proliferation was due to
cystatin C. Moreover, cystatin C stimulated NSPC prolifera-
FIGURE 5. Effect of neurosphere conditioned medium on NSPC proliferation. A, effect of unconditioned medium, conditioned medium from Tg2576
neurosphere cultures (CM-Tg2576), and conditionedmedium fromC57Bl/6xSJL neurosphere cultures (CM-C57Bl/6xSJL) on the growth of C57Bl/6xSJL NSPCs.
Medium was conditioned for 7 days prior to adding to cultures to test for the effect on proliferation over a period of 5 days. Cell number is shown as a the
percentage of the fluorescence intensity measured in an alamarBlue assay when compared with control (unconditioned medium). Values are means 
S.E. * significantly different from unconditioned medium (control) (p 0.05). ** significantly different from unconditioned (control) medium and from
CM-C57Bl/6xSJL (p0.05).B, effect of unconditionedmedium, conditionedmedium fromAPPknock-outneurosphere cultures (CM-APP-KO), andconditioned
medium from C57Bl/6 neurosphere cultures (CM-C57Bl/6) on the growth of wild-type (C57Bl/6) NSPCs. Cell number is represented by the percentage of the
fluorescence intensity measured in an alamarBlue assay when compared with control (unconditioned medium). Values are means  S.E. *  significantly
different fromunconditioned (control)medium (p 0.05). *** significantly different fromunconditioned (control)mediumand fromCM-C57Bl/6 (p 0.05).
FIGURE 6. Effect of sAPP and A peptides on NSPC proliferation. Isolated NSPCs were prepared from C57Bl/6xSJL mice and cultured adherently on
poly-L-lysine. The figure shows cell number as represented by the percentage of the fluorescence intensity measured in an alamarBlue assay. Values are
means  S.E. A, effect of recombinant sAPP, A1–40, and A1–42 on NSPC proliferation. B, immunoprecipitation of 98% of the sAPP from Tg2576
conditionedmediumdidnotdecrease the ability of the conditionedmedium to increaseNSPCproliferation. The figure shows theeffect of Tg2576 conditioned
mediumafter immunoprecipitationwith an immunoglobulin fraction (IP: Ig) and after immunoprecipitationwithmAb6E10 (IP: 6E10). The inset showsWestern
blot (WB) analysis of the conditionedmedium from both fractions. * significantly different from control incubation. ** significantly different from control
incubation, but not significantly different from incubation of immunoglobulin fraction.
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tion, and levels in the culturemediumwere correlatedwithAPP
expression, clearly supporting this idea.
Interestingly, in experiments with APP-KO cells, we found
that there was a significant residual effect of APP, even after
removal of most of the cystatin C. Cystatin C-immunodepleted
C57Bl/6 conditioned medium was still significantly more
potent in stimulating the proliferation of APP-KO cells than
the corresponding immunodepleted APP-KO conditioned
medium (Fig. 8D). This suggests the possibility that there is an
additional, as yet unidentified, secretedmolecule that also con-
tributes to APP-induced NSPC proliferation. This effect was
not seen in experiments where we tested the effect of condi-
tioned medium on C57Bl6xSJL cells (Fig. 8C). The reason for
this difference is unclear, but it could relate to the fact that the
APP-KO cells may bemore sensitive to this unidentified factor.
We also found that a greater proportion of Tg2576 cells
expressed III-tubulin when NSPCs were incubated in a
medium that promotes differentiation. This effect on neuro-
genesis could have been mediated by sAPP, similar to some
previous studies (9, 27, 38), or by cystatin C.
FIGURE 7. Levels of cystatin C and expression of cystatin C mRNA. The
figure shows representative Western blots and quantification of cystatin C
immunoreactivity by image capture analysis (A–D). Values are means  S.E.
(n 4). A and C, Western blotting analysis of cystatin C (CysC) in conditioned
medium (A) and cell lysate (C) of Tg2576mouse NSPC cultures and the corre-
sponding background strain (C57Bl/6xSJL) cultures. Each lane represents a
sample from a different line of NSPCs. B and D, Western blotting analysis of
cystatin C in conditioned medium (B) and cell lysate (D) of APP-KO mouse
NSPC cultures and the corresponding background strain (C57Bl/6) cultures.
Each lane represents a sample from a different line of NSPCs. E and F, cystatin
C mRNA expression determined by real-time PCR. Values are means  S.E.
(n 6). * significantly different (p 0.05) from corresponding background
strain control cultures (Student’s t test).
FIGURE 8. Role of secreted cystatin C in stimulating NSPC proliferation.
The number of viable cells was calculated from the fluorescence intensity in
an alamarBlue assay. A, effect of cystatin C on NSPC proliferation. Dissociated
neurosphere-derived cells were plated on poly-L-lysine-coated plates and
then incubated for 5 days in proliferation medium containing various con-
centrations of cystatin C. Values are means S.E., (n 4) and shown as the
percentage of the control value (no added cystatin C). * significantly differ-
ent from the control group (no cystatin C) (p  0.05, ANOVA with post hoc
Tukey’s test). B, Western blot analysis of cystatin C (CysC) immunoreactivity in
cell culture medium. Panel i, comparison of the level of cystatin C in 48 l of
C57Bl/6xSJL cell mediumwhen comparedwith 100 ng of recombinant cysta-
tin C. Panel ii, Western blot stained for cystatin C showing efficiency of immu-
nodepletion of cystatin C from the C57Bl/6xSJL and Tg2576 conditioned
medium. Ig  medium after immunodepletion with control immunoglobu-
lin; CCmedium after immunodepletion with cystatin C antibody. Panel iii,
Western blot stained for cystatin C showing efficiency of immunoprecipita-
tion of cystatin C from the C57Bl/6 and APP-KO cell medium. C and D, immu-
noprecipitation of cystatin C removes the APP-induced growth factor that
stimulates proliferation. C, C57Bl/6xSJL neurosphere-derived cells were incu-
bated with unconditioned medium or conditioned medium from C57Bl/
6xSJL cultures or Tg2576 cultures that was previously immunoabsorbedwith
a nonspecific Ig fraction (IP: Ig) or with an anti-cystatin C antibody (IP: CC).
D, APP-KO neurosphere-derived cells were incubated with unconditioned
medium or conditioned medium from C57Bl/6 cultures or APP-KO cultures
that was previously immunoabsorbed with a nonspecific Ig fraction (IP: Ig) or
with an anti-cystatin C antibody (IP: CC). Values in panels C andD aremeans
S.E. (n 4) and shown as the percentage of themean of the values for uncon-
ditionedmedium. * significantly different (p 0.05, ANOVA with post hoc
Tukey’s test).
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Themechanism of the APP-stimulated increase in cystatin C
andNSPC proliferation is also not yet known. Our experiments
suggest that there may be twomechanisms involved. Real-time
PCR experiments showed that cystatin C expression was
decreased in APP-KO cells when compared with the corre-
sponding background strain cells. As the extracellular domain
of APP (i.e. sAPP) was not found to stimulate proliferation,
this suggests that the APP intracellular domain (AICD) may be
involved in mediating this effect. Indeed, based on an analogy
with the notch intracellular domain (NICD), which is also
released by -secretase (39), a number of studies suggest that
the AICD may regulate gene expression (40). Whether AICD
regulates the expression of cystatin C is not yet known and will
require further studies.
However, cystatin C expression was not increased in Tg2576
cells when compared with the corresponding background
strain cells. Indeed, a surprising finding was that although
cystatin C secretion was higher in the Tg2576 conditioned
medium (Fig. 7A), levels were lower in the cell lysate (Fig. 7C).
This suggests the possibility that the higher levels of cystatin C
in the Tg2576 culture mediummay be due to an increased rate
of cystatin C secretion with a concomitant decrease in intracel-
lular cystatin C. The idea that increased APP may result in
increased secretion is consistent with published studies. For
example, Lee et al. (41) reported that APP overexpression can
increase vesicle exocytosis in PC12 cells. Furthermore, the
cytoplasmic domain of APP can interact with proteins associ-
ated with synaptic vesicle release such as synaptotagmin-1 (42).
Thus, we speculate that the cytoplasmic domain of APP may
possess two different functions: 1) it may be translocated to the
nucleus to alter gene expression or 2) it may interact with pro-
teins on the cytoplasmic leaflet of the plasmamembrane to alter
events such as exocytosis. The balance of these two functions
could conceivably be regulated by the level of expression ofAPP
and the degree of saturation of binding to different adaptor
proteins.
Finally, our study may have implications for understanding
the role of cystatin C in the pathogenesis of AD. It is interesting
to note that a polymorphism (G73A) in cystatin C has been
linked to AD (43). Furthermore, cystatin C is increased in
regions aroundA deposits in the ADbrain (44, 45), suggesting
that it may play a role in pathogenesis or in response to A
pathology. Indeed, two groups, Mi et al. (46) and Kaeser et al.
(47), found that cystatin C may have a protective effect as APP
transgenic mice that had higher cystatin C expression were
found to have diminished A deposition. As APP is also
increased in dystrophic neurites around amyloid plaques, it is
tempting to speculate that increased cystatin C may be due to
an increase in local APP expression. Further studies on the role
of APP in regulating cystatin C expression in the AD brain may
help to identify new targets for drug development in AD.
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